Tag: molecular diagnostics
December 6, 2018
Myriad Validates Polygenic Score to Predict Breast Cancer Risk
Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the... May 8, 2018
Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results
Myriad Genetics (NASDAQ:MYGN), a global leader in molecular diagnostics and personalized medicine, today announced financial results for its fiscal third-quarter... May 7, 2018
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
HTG Molecular Diagnostics (NASDAQ:HTGM) a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A., a provider of...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ. April 13, 2018
Olerup QTYPE® Receives CE Mark Certification
CareDx (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for... April 10, 2018
CareDx Launches HeartCare for Heart Transplant Recipients
CareDx (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for...
April 1, 2018